56 signals · alpha_vantage, bluesky, h1b_lca +2 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Elevated risk signals — operational or reputational pressure patterns observed.
Auto-generated from public signals — AI summary pending. Based on 4 recent signals.
Abbott Laboratories to spin off nutrition unit at centre of baby formula lawsuits—Abbott is the latest company to resort to shedding its nutrition business amid a wave of class action lawsuits and product recalls… www.ft.com/content/7f40... @mroliverbarnes.bsky.social @financialtimes.com
Abbott Laboratories to spin off nutrition unit at centre of baby formula lawsuits—Abbott is the latest company to resort to shedding its nutrition business amid a wave of class action lawsuits and product recalls… www.ft.com/content/7f40...
Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says Yahoo Finance
Diversified health care products company.
Based on 56 signals across 5 sources · snapshot 2 Nov 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Abbott Laboratories is negative based on public signals as of 2 Nov 2026.
Based on 56 signals across 5 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Abbott Laboratories' Q3 Somewhat a 'Mixed Bag' With Softened Outlook, Nutrition Spinoff, Oppenheimer Says marketscreener.com